Skip to product information
1 of 7

Molnlycke

Molnlycke Mepilex XT Foam Dressing Soft Absorbent Wound Care

Molnlycke Mepilex XT Foam Dressing Soft Absorbent Wound Care

Regular price $156.00 SGD
Regular price Sale price $156.00 SGD
Sale Sold out
Shipping calculated at checkout.
Size
Packaging
Clinical Summary: Mölnlycke Mepilex XT is a multi-layer polyurethane foam dressing incorporating Safetac® soft silicone wound contact technology, engineered to manage both low- and high-viscosity exudate in moderate to heavily exuding wounds while minimising periwound maceration and trauma during dressing changes. The hydrophobic wound contact layer repels wound exudate from re-adherence to granulating tissue, and the multi-directional spread foam core distributes fluid evenly to prevent pooling. Classified as a Class IIa medical device under EU MDR 2017/745, manufactured by Mölnlycke Health Care AB (Sweden) under ISO 13485:2016, and available in Singapore through EMIS for hospital, clinic, and nursing home procurement.

Mölnlycke Mepilex XT Foam Dressing — Product Overview

Mepilex XT is a soft, conformable multi-layer foam dressing developed by Mölnlycke Health Care for the management of moderate to heavily exuding acute and chronic wounds. The wound contact layer utilises Safetac® technology — a proprietary soft silicone adhesive that bonds to dry periwound skin without adhering to moist wound tissue, enabling atraumatic removal that minimises pain, wound disruption, and epidermal stripping at dressing changes. The XT (eXtended Technology) designation refers to the dual-layer foam core architecture: an inner hydrophilic foam absorbs and locks exudate away from the wound surface, while an outer hydrophobic layer prevents fluid strike-through and maintains a moisture-balanced environment that supports granulation and epithelialisation without maceration.

The dressing's exudate management profile encompasses both aqueous (low-viscosity) exudate from clean granulating wounds and thick (high-viscosity) exudate from infected, sloughy, or necrotic wounds, making it suitable across a broad range of wound stages without requiring a dressing change when wound characteristics evolve. Mepilex XT is manufactured by Mölnlycke Health Care AB (Gothenburg, Sweden) under ISO 13485:2016 quality management standards and is classified as a Class IIa medical device under EU MDR 2017/745. Products are registered on the Singapore Medical Device Register (SMDR) via the HSA MEDICS portal and distributed in Singapore by EMIS for procurement by hospitals, specialist wound clinics, nursing homes, and home care providers.

Product Specifications

Parameter Specification
Manufacturer Mölnlycke Health Care AB, Gothenburg, Sweden
Product Line / Technology Mepilex XT; Safetac® soft silicone wound contact layer
Available Sizes (via EMIS) 10 cm × 10 cm (5 pieces/box); 20 cm × 20 cm (5 pieces/box)
Dressing Layers 1. Safetac® soft silicone wound contact layer (hydrophobic); 2. Inner hydrophilic foam (exudate absorption); 3. Outer hydrophobic foam (strike-through barrier); 4. Water-vapour permeable backing film
Exudate Management Low- and high-viscosity exudate; multi-directional fluid spread to prevent pooling; maceration prevention
Wear Time Up to 7 days (exudate-dependent); change when saturated or per clinical assessment
Sterility Sterile; single use; validated per ISO 11135 (ethylene oxide sterilisation)
Latex Content Latex-free
Biocompatibility ISO 10993 biocompatibility evaluated
Medical Device Classification Class IIa medical device under EU MDR 2017/745; CE marked
Manufacturing Standard ISO 13485:2016 (Medical Device Quality Management System)
Singapore Registration Verify on SMDR via HSA MEDICS portal; Class B medical device under Singapore Health Products Act (Cap. 122D)
Price (Singapore) SGD 44.00 (10×10 cm, 5 pcs); SGD 156.00 (20×20 cm, 5 pcs) via EMIS

Clinical Indications

  • Pressure injuries (NPUAP/EPUAP Stage II–IV): Mepilex XT manages moderate-to-heavy exudate in sacral, heel, and trochanteric pressure injuries; Safetac® technology is particularly indicated where fragile periwound skin is at risk of mechanical trauma from adhesive removal.
  • Venous leg ulcers (VLU) with moderate to heavy exudate: Absorbs chronic wound fluid including fibrin-rich and viscous exudate characteristic of VLU; compatible with compression bandage systems per EWMA consensus guidelines.
  • Diabetic foot ulcers (DFU), Wagner Grade 1–2: Appropriate for non-infected, non-ischaemic DFU with exudate; the atraumatic contact layer reduces pain at dressing changes, improving patient concordance in chronic foot wound management programmes.
  • Post-surgical wounds with moderate drainage: Suitable for closed surgical incisions with peri-incisional drainage or for dehisced wounds in secondary intention healing; wear time of up to 7 days reduces dressing change frequency and nursing resource utilisation.
  • Traumatic wounds and skin tears: Safetac® contact layer is appropriate for partial-thickness traumatic wounds and skin tears where standard adhesive dressings risk epidermal stripping at removal, particularly in elderly or immunocompromised patients.
  • Oncology wound care and radiation dermatitis: The gentle silicone contact interface minimises mechanical trauma and maceration in patients with treatment-related skin fragility receiving chemotherapy or radiotherapy.

Frequently Asked Questions

Q: What is Safetac® technology and how does it differ from standard foam dressing adhesives?
A: Safetac® is Mölnlycke's proprietary soft silicone adhesive technology that seals to dry, intact periwound skin without bonding to moist wound tissue. At removal, the dressing peels away cleanly from the wound surface, causing minimal pain, epidermal disruption, or wound bed disturbance. Standard adhesive foam dressings use acrylic adhesives that bond non-selectively, increasing the risk of epidermal stripping and pain at dressing changes, particularly in patients with fragile skin, oedematous tissue, or wounds treated with topical steroids. Clinical studies have demonstrated significantly lower pain scores at dressing change with Safetac®-based dressings versus acrylic-adhesive alternatives.

Q: How often should Mepilex XT be changed?
A: Mepilex XT is designed for extended wear of up to 7 days, but actual change frequency is governed by exudate volume, signs of leakage, strike-through saturation, or deterioration of the periwound seal. Heavily exuding wounds may require changes every 2–3 days initially; as healing progresses and exudate reduces, wear time can be extended. Per WUWHS exudate management guidelines, dressing selection and change frequency should be reassessed at each dressing change based on wound progress and exudate characteristics.

Q: Can Mepilex XT be used under compression bandaging for venous leg ulcers?
A: Yes. Mepilex XT is compatible with multi-layer compression bandage systems (Profore, Coban2, or equivalent) used in venous leg ulcer management. The dressing's conformability and low-profile design allow it to lie flat under compression without creating pressure points. Where high exudate volume is present initially, the 20×20 cm size may be cut to wound shape (non-bordered variant) before application of compression. Confirm compatibility with the specific compression system's application protocol.

Q: Is Mepilex XT registered under Singapore's HSA as a medical device?
A: Mölnlycke Health Care products including the Mepilex range are CE-marked Class IIa medical devices under EU MDR 2017/745 and manufactured under ISO 13485:2016. For Singapore regulatory status, individual product listings should be verified on the Singapore Medical Device Register (SMDR) via HSA's MEDICS online portal. As a Class B medical device under the Singapore Health Products Act (Cap. 122D), procurement by healthcare institutions does not require a product licence but importers and suppliers must be licensed. EMIS operates as a licensed medical device supplier in Singapore.

Q: What sizes of Mepilex XT are available through EMIS and in what pack quantities?
A: EMIS currently supplies Mepilex XT in two sizes: 10 cm × 10 cm (SGD 44 per box of 5 pieces) and 20 cm × 20 cm (SGD 156 per box of 5 pieces). For other sizes or large institutional quantities, contact EMIS for special order availability and bulk pricing. Mölnlycke's full Mepilex XT size range also includes 15×15 cm and 20×50 cm formats for cavity and larger wound applications.

 

View full details